1,3-dipropyl-8-cyclopentylxanthine has been researched along with kf 17837s in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C | 1 |
| Abiru, T; Endo, K; Machida, H | 1 |
| Constantino, MD; Cunha, RA; Fredholm, BB; Johansson, B; Sebastião, AM | 1 |
| Bauer, J; Fiebich, BL; Heese, K; Otten, U | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Mi, Z | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Keller, PJ; Mi, Z; Rosselli, M | 1 |
7 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and kf 17837s
| Article | Year |
|---|---|
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles | 1997 |
Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein.
Topics: Adenosine; Alkynes; Animals; Endothelium, Vascular; Femoral Artery; Femoral Vein; Male; Muscle Contraction; Muscle, Smooth, Vascular; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Serotonin; Vasodilator Agents; Xanthines | 1995 |
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Topics: 2-Chloroadenosine; Adenosine; Animals; Binding, Competitive; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Hippocampus; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthines | 1996 |
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Antihypertensive Agents; Bucladesine; Colforsin; Gene Expression; Microglia; Nerve Growth Factors; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilator Agents; Xanthines | 1997 |
Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Adult; Animals; Aorta, Thoracic; Cell Division; Cells, Cultured; Collagen; Dipyridamole; DNA; Humans; Kinetics; Male; Muscle, Smooth, Vascular; Phenethylamines; Purinergic P1 Receptor Antagonists; Rats; Receptor, Adenosine A2B; Receptors, Purinergic P1; Thymidine; Xanthines | 1998 |
Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Animals; Aorta, Abdominal; Cells, Cultured; Collagen; Cyclic AMP; Dipyridamole; Kinetics; Leucine; Male; Muscle, Smooth, Vascular; Proline; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Xanthines | 1999 |
Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway.
Topics: Adenosine; Adenylyl Cyclases; Animals; Antihypertensive Agents; Aorta; Cell Division; Cells, Cultured; Colforsin; Cyclic AMP; DDT; Enzyme Inhibitors; Estradiol; Fetal Proteins; Male; Muscle, Smooth, Vascular; Proline; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Thionucleotides; Thymidine; Tritium; Xanthines | 2000 |